药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Pirbuterol
Tandutinib
The risk or severity of QTc prolongation can be increased when Tandutinib is combined with Mirabegron.
Pirbuterol
Methsuximide
The risk or severity of QTc prolongation can be increased when Methsuximide is combined with Mirabegron.
Pirbuterol
Farnesyl thiopyrophosphate
The risk or severity of QTc prolongation can be increased when Farnesyl thiopyrophosphate is combined with Mirabegron.
Pirbuterol
Fleroxacin
The risk or severity of QTc prolongation can be increased when Fleroxacin is combined with Mirabegron.
Pirbuterol
Vorinostat
The risk or severity of QTc prolongation can be increased when Vorinostat is combined with Mirabegron.
Pirbuterol
Pheniramine
The risk or severity of QTc prolongation can be increased when Pheniramine is combined with Mirabegron.
Pirbuterol
Ajmaline
The risk or severity of QTc prolongation can be increased when Ajmaline is combined with Mirabegron.
Pirbuterol
Dexpropranolol
The therapeutic efficacy of Mirabegron can be decreased when used in combination with Dexpropranolol.
Pirbuterol
Belantamab mafodotin
The serum concentration of Belantamab mafodotin can be increased when it is combined with Mirabegron.
Pirbuterol
Prednisolone phosphate
The serum concentration of Prednisolone phosphate can be increased when it is combined with Mirabegron.
Pirbuterol
Remdesivir
The serum concentration of Remdesivir can be increased when it is combined with Mirabegron.
Pirbuterol
Fostemsavir
The serum concentration of Fostemsavir can be increased when it is combined with Mirabegron.
Pirbuterol
Ripretinib
The serum concentration of Ripretinib can be increased when it is combined with Mirabegron.
Pirbuterol
Selumetinib
The serum concentration of Selumetinib can be increased when it is combined with Mirabegron.
Pirbuterol
Favipiravir
The serum concentration of Mirabegron can be increased when it is combined with Favipiravir.
Pirbuterol
Lemborexant
The serum concentration of Lemborexant can be increased when it is combined with Mirabegron.
Pirbuterol
Tazemetostat
The serum concentration of Tazemetostat can be increased when it is combined with Mirabegron.
Pirbuterol
Darolutamide
The serum concentration of Darolutamide can be increased when it is combined with Mirabegron.
Pirbuterol
Enfortumab vedotin
The serum concentration of Enfortumab vedotin can be increased when it is combined with Mirabegron.
Pirbuterol
Cobicistat
The serum concentration of Mirabegron can be increased when it is combined with Cobicistat.